As Merck & Co. rolls out a…
As Merck & Co. rolls out a widespread cost-cutting initiative, [...]
As Merck & Co. rolls out a widespread cost-cutting initiative, [...]
Quoin Pharmaceuticals has ended development of two programs, pulling back [...]
Bausch Health has struck a deal to buy Durect for [...]
Many pharmaceutical products made in Europe will face a 15 [...]
The conglomerate was viewed as one of the most successful [...]
After assuring investors last week that beleaguered Sarepta Therapeutics would [...]
As interest in injectable biologics for cancer and other diseases [...]
After months of searching for strategic options, Adaptimmune is offloading [...]
MapLight Therapeutics has raised a $372.5 million series D round, [...]
Eduard Yusupov and Diana Fuzailov sold supplements through their company, [...]